论文部分内容阅读
卵巢癌是危及妇女生命的重要疾病之一,其早诊断已成为临床关注的课题。CA72-4为肿瘤相关糖蛋白(TAG-72),是一种较新的肿瘤标志物。本文采用固相酶联免疫吸附试验测定卵巢肿瘤患者血清CA72-4水平,观察其在卵巢肿瘤诊断中的意义。 1 对象与方法 1.1 对象 选取1997年5月至1998年10月在我院妇科住院治疗的卵巢良、恶性肿瘤病例107例。均经病理学检查证实,卵巢恶性肿瘤72例(恶性组),平均年龄43.5岁(23～67岁)。其中原发性卵巢癌68例(浆液性癌21例,粘液性癌34
Ovarian cancer is one of the important diseases endangering women’s life, and its early diagnosis has become a clinical concern. CA72-4 is a tumor-associated glycoprotein (TAG-72), a relatively new tumor marker. In this paper, the level of serum CA72-4 in patients with ovarian cancer was determined by solid-phase enzyme-linked immunosorbent assay, and its significance in the diagnosis of ovarian tumors was observed. 1 Subjects and Methods 1.1 Object Selection May 1997 to October 1998 in our hospital gynecological hospitalized cases of benign and malignant ovarian 107 cases. Pathological examination confirmed that 72 cases of ovarian cancer (malignant group), mean age 43.5 years (23 to 67 years old). 68 cases of primary ovarian cancer (serous carcinoma in 21 cases, mucinous carcinoma 34